Entrada Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 875K | 1.3M | 1.6M | 1.9M | 20.6M | 37.4M | 19.6M | 94.7M |
| Cost of Goods Sold | 805K | 886K | 38.4M | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 70K | 413K | -36.7M | 1.9M | 20.6M | 37.4M | 19.6M | 94.7M |
| R&D Expenses | 33.1M | 34.0M | 38.4M | 37.9M | 32.1M | 33.4M | 31.3M | 32.0M |
| Operating Expenses | 42.4M | 42.6M | 10.3M | 48.8M | 42.3M | 43.3M | 41.2M | 41.3M |
| Operating Income | -42.3M | -42.2M | -47.1M | -46.8M | -21.8M | -5.9M | -21.7M | 53.4M |
| Other Income / Gains | 2.6M | 3.1M | 3.6M | 3.9M | 4.4M | 5.1M | 5.8M | 4.4M |
| Net Income | -39.7M | -39.2M | -44.1M | -43.1M | -17.3M | 1.1M | -14.0M | 55.0M |
| EPS (Diluted) | -0.95 | -0.95 | -1.06 | -1.04 | -0.42 | 0.028 | -0.35 | 1.61 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.08 | 0.318 | -22.768 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 10.1M | 9.6M | 10.3M | 10.9M | 10.3M | 9.9M | 10.0M | 9.2M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 10.1M | 9.6M | 10.3M | 10.9M | 10.3M | 9.9M | 10.0M | 9.2M |
| Other Expenses | -805K | -886K | -38.4M | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 43.2M | 43.5M | 48.7M | 48.8M | 42.3M | 43.3M | 41.2M | 41.3M |
| Interest Income | 2.6M | 3.1M | 3.6M | 3.9M | 4.4M | 5.1M | 5.8M | 4.4M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 805K | -2.8M | 1.2M | 1.0M | 946K | 992K | 937K | 910K |
| Ebitda | -38.9M | -41.9M | -42.3M | -41.9M | -16.4M | 253K | -15.0M | 58.7M |
| Ebitdaratio | -44.427 | -32.222 | -26.177 | -21.483 | -0.798 | 0.007 | -0.764 | 0.62 |
| Operating Income Ratio | -48.346 | -32.493 | -29.152 | -24.025 | -1.06 | -0.157 | -1.107 | 0.564 |
| Income Before Tax | -39.7M | -39.1M | -43.5M | -42.9M | -17.3M | -739K | -15.9M | 57.8M |
| Income Before Tax Ratio | -45.347 | -30.079 | -26.939 | -22.013 | -0.844 | -0.02 | -0.812 | 0.61 |
| Income Tax Expense | 38K | 92K | 654K | 178K | 0 | -1.9M | -1.9M | 2.8M |
| Net Income Ratio | -45.391 | -30.149 | -27.344 | -22.104 | -0.844 | 0.03 | -0.717 | 0.581 |
| Epsdiluted | -0.95 | -0.95 | -1.06 | -1.04 | -0.42 | 0.026 | -0.35 | 1.55 |
| Weighted Average Shs Out | 41.8M | 41.4M | 41.5M | 41.3M | 41.1M | 40.8M | 40.6M | 34.2M |
| Weighted Average Shs Out Dil | 41.8M | 41.4M | 41.5M | 41.3M | 41.1M | 43.1M | 40.6M | 35.5M |